The disclosure relates to a tubular structure for producing droplets and a method for producing droplets.
Droplet digital polymerase chain reaction (ddPCR) is a method of performing absolute quantification for nucleic acid molecules. In a general ddPCR, a droplet generator may be used to divide a sample into hundreds or even tens of thousands of nanoliter level or even picoliter level single water-in-oil droplets. In these droplets, some of the droplets do not contain nucleic acid molecules or only contain a single nucleic acid molecule. Thereafter, PCR amplification is performed on a specimen in the droplets, and then a fluorescent signal is applied to perform detection and statistical analysis. Compared with a conventional quantitative PCR, the digital PCR may demonstrate a high sensitivity, high accuracy and multi-target quantitative ability.
At present, a method of using a commercial ddPCR machine for detection may include following steps. Droplets are generated by using a droplet generator. The generated droplets are placed in a 96-well plate sealer for sealing. The sealed 96-well plate is placed in a PCR machine to perform nucleic acid amplification. The droplets subjected to the nucleic acid amplification are extracted to a droplet detector to perform optical interpretation. Since each operation process is processed in a different container and a different machine, the sample is liable to have some loss during a transfer process and process automation is quite difficult. Meanwhile, the ddPCR process requires a large number of consumables, especially the droplet generator used to generate the droplets, which cannot be reused due to a concern of cross-contamination of specimens, causing the cost of detection to be increased.
At present, there is a lack of product that may be conveniently and accurately used in the ddPCR.
The disclosure provides a tubular structure for producing droplets and a method of using the tubular structure to produce droplets. The tubular structure of the disclosure has microchannels to separate a water phase reagent, and the water phase reagent forms droplets with a water-in-oil structure through a shearing effect of an oil phase liquid in the tubular structure. Since the tubular structure of the disclosure may produce droplets in a single tubular structure, it occupies less space than an existing multi-slot structure. In some embodiments of the disclosure, the tubular structure of the disclosure may be continuously used for implementing ddPCR or other biochemical reactions after the droplets are produced, and droplet detection or droplet separation may be performed in situ without removing the droplets to another reaction container or machine. In this case, droplet production, subsequent biochemical reaction (such as the PCR), final detection or collection of the droplets, etc., may all be completed in the single tubular structure of the disclosure without replacing a different container consumable or a reaction slot. Therefore, accurate biochemical reaction and/or detection may be performed free of the concern of cross-contamination, by which not only is the cost of the biochemical detection reduced, but the operation is also convenient and an effect of program automation is achieved.
The tubular structure of the disclosure includes an outer tube, a reagent containing region, a first microchannel, an oil filling channel, an exhaust channel, an oil storage region, a droplet containing region, and a second microchannel. The reagent containing region is disposed on a middle portion of an upper portion inside the tubular structure and extends along a tube body length direction. The first microchannel is disposed inside the tubular structure and is located below the reagent containing region. A first end of the first microchannel is connected to the reagent containing region, and the first microchannel communicates with the reagent containing region through the connected first end, and the first microchannel extends along the tube body length direction. The oil filling channel and the exhaust channel are disposed at the upper portion inside the tubular structure and are respectively located at two opposite sides of the reagent containing region, wherein the oil filling channel and the exhaust channel extend along the tube body length direction. The oil storage region is disposed at a lower portion inside the tubular structure, wherein the oil filling channel is connected above the oil storage region and communicates with the oil storage region. The droplet containing region is disposed at the lower portion inside the tubular structure, wherein the exhaust channel is connected above the droplet containing region and communicates with the droplet containing region. The second microchannel is located between the oil storage region and the droplet containing region and is connected to the oil storage region and the droplet containing region, wherein the second microchannel extends along a radial direction perpendicular to the tube body length direction. The first microchannel is vertically connected to the second microchannel through a second end opposite to the first end, and the second microchannel communicates with the oil storage region, the droplet containing region and the first microchannel. A diameter of the first microchannel is less than a diameter of the second microchannel.
The disclosure provides a tubular structure for producing droplets including a reagent containing inner tube and an oil agent containing outer tube. The reagent containing inner tube is disposed at a middle portion inside the tubular structure and extends along a tube body length direction, wherein the reagent containing inner tube has a first cavity to contain a reagent solution and the reagent containing inner tube includes a microwell array located at a lower portion of the reagent containing inner tube. The oil agent containing outer tube is located outside the reagent containing inner tube and surrounds a side portion and the lower portion of the reagent containing inner tube, wherein the oil agent containing outer tube has a second cavity to contain an oil body, the microwell array is located between the reagent containing inner tube and the oil agent containing outer tube, and the reagent solution in the reagent containing inner tube is separated in the oil body in the oil agent containing outer tube to form the droplets through the microwell array.
The disclosure provides a method for producing droplets including following steps. A tubular structure is provided, and the tubular structure includes a reagent containing region, an oil agent containing region, a droplet containing region, and a first microchannel and a second microchannel disposed inside the tubular structure, wherein the first microchannel is connected below the reagent containing region and communicates with the reagent containing region, and the second microchannel is connected between the oil agent containing region and the droplet containing region and communicates with the oil agent containing region and the droplet containing region, the first microchannel is vertically connected to the second microchannel, and the first microchannel and the second microchannel communicate with each other. A reagent solution containing a specimen is added to the reagent containing region. An oil agent is added to the oil agent containing region. The reagent solution is driven to pass through the first microchannel and the oil agent is driven to flow into the second microchannel, such that the oil agent wraps the reagent solution to form the droplets.
Based on the above description, the tubular structure of the disclosure uses a three-dimensional structure formed by intersected three-dimensional perpendicular flow paths of the first microchannel and the second microchannel to construct a droplet generation mechanism on a non-same plane, and produce droplets in the microchannel in a water-in-oil manner. Operations from droplet generation, droplet detection, droplet separation to the final droplet collection may all be completed within a same tubular structure consumable, by which not only are errors of human operations in the detection process reduced, reliability increased and detection functionality improved, but low-cost, accurate and efficient biochemical detection is also achieved due to reduction of the use of consumables and a sample loss.
Several exemplary embodiments accompanied with figures are described in detail below to further describe the disclosure in details.
The accompanying drawings are included to provide further understanding, and are incorporated in and constitute a part of this specification. The drawings illustrate exemplary embodiments and, together with the description, serve to explain the principles of the disclosure.
Embodiments are described in detail below with reference to the drawings, but the provided embodiments are not intended to limit a scope covered by the disclosure. In addition, the drawings are for illustrative purposes only, and are not necessarily drawn to scale. For easy understanding, the same devices in the following description will be indicated by the same symbols. In addition, the terms “contain”, “include”, “have”, etc. used in the text are all open terms, which means “include but not limited to”. Moreover, directional terminologies, such as “up”, “down” etc., mentioned in the text are only used with reference to the orientation of the figure(s) being described and are not intended to be limiting of the disclosure.
In the specification, droplet is a kind of micro drop having an inner-outer double-layer structure, in which an inner layer is a water phase and an outer layer is an oil phase. A volume of the droplet may be, for example, less than about 1 μL (or between about 1 μL and 1 nL or between about 1 μL and 1 pL), less than about 1 nL (or between about 1 nL and 1 pL), or less than about 1 pL (or between about 1 pL and 1 fL), etc. The droplet may have a diameter (or an average diameter) of less than about 1000, 100, 10, or 1 μm, or a diameter (or the average diameter) of about 1000 to 10 μm, etc. The droplet may be spherical or non-spherical. The droplets may respectively wrap a sample to be tested that is not less than a half of the size of the droplet for respective quantitative counting.
In the specification, “reagent solution” refers to a water phase reagent used to form the inner layer of the droplet, which may be formed by, for example, mixing a specimen, water, and/or a PCR reagent. For example, the specimen may include a biological specimen (such as blood, plasma, saliva, semen, ovum, urine), biomolecules, nano particles, viruses, a food specimen or an environmental specimen, etc. For example, the specimen may be nucleic acid fragments (including DNA or RNA, etc.) or templates extracted from human or animal blood, plasma, saliva, semen, ovum, urine, molecular organism, viruses or other sources, or the specimen may be a liquid specimen obtained by digesting and diluting food or traditional Chinese medicinal materials, or an environmental specimen such as drinking water, washing water, irrigation water, etc. The specimen may include, for example, a coloring agent, a fluorescent label, or a magnetic label to facilitate subsequent detection. The PCR reagent may include deoxy-ribonucleotide triphosphated—NTP, magnesium ions, potassium chloride, potassium sulfate, enzyme, primer, probe, buffer, cell tissue lysis buffer, nano particles, etc., but the disclosure is not limited thereto. For example, the reagent solution may also contain fluorescent dye for subsequent detection.
In the specification, “oil agent” refers to a hydrophobic substance used to form the oil phase of the droplet outer layer. The oil agent may include oil with heat resistance, which is, for example, silicone oil, vegetable oil, fluorinated oil such as FC-40, FC-7500, or mineral oil such as alkane, or a combination thereof, but the disclosure is not limited thereto.
Referring to
A method of using the tubular structure 100 to produce droplets includes following steps. A reagent solution is placed in a first cavity 111 of the reagent containing inner tube 101. An oil agent is placed in a second cavity 112 of the oil agent containing outer tube 102. An external driving force such as an air pressure is applied to make the reagent solution in the first cavity 111 to pass through the micro-array type micropores 105 to form micro droplets and enter the second cavity 112 to combine with the oil agent in the second cavity 112 to form water-in-oil droplets.
The tubular structure 100 of the first embodiment of the disclosure may be manufactured by, for example, transparent acrylic by using a molding method. In detail, the reagent containing inner tube 101, the oil agent containing outer tube 102 and the annular support rib 104 are respectively manufactured through precision processing, and the manufactured components are combined to form the tubular structure 100, but the disclosure is not limited thereto.
Referring to
In the embodiment of the disclosure, an inner diameter of the first microchannel 215 may be, for example, 0.05 to 0.5 mm, and an inner diameter of the second microchannel 245 may be, for example, 0.1 to 1 mm. In addition, the inner diameter of the first microchannel 215 may be less than the inner diameter of the second microchannel 245, so that the formed droplet may be completely wrapped by an oil film.
Referring to
Referring to
In the embodiment of the disclosure, an inner diameter of the first microchannel 315 may be, for example, 0.05 to 0.5 mm, and an inner diameter of the second microchannel 345 may be, for example, 0.1 to 1 mm. In addition, the inner diameter of the first microchannel 315 may be less than the inner diameter of the second microchannel 345, so that the formed droplet may be completely wrapped by the oil film.
Referring to
Referring to
In the embodiment of the disclosure, an inner diameter of the first microchannel 415 may be, for example, 0.05 to 0.5 mm, and an inner diameter of the second microchannel 445 may be, for example, 0.1 to 1 mm. In addition, the inner diameter of the first microchannel 415 may be less than the inner diameter of the second microchannel 445, so that the formed droplet may be completely wrapped by the oil film.
The tubular structure 400 is similar to the tubular structure 300, and the difference there between is that the tubular structure 400 further includes the upper droplet containing region 470 and the upper pre-sealed oil storage region 460. Therefore, when the tubular structure 400 is used to produce droplets, the oil agent has been pre-sealed in the pre-sealed oil storage structure, and the reagent solution may be directly filled in the reagent containing region 410, and the syringe pump is used to compress air to simultaneously drive the reagent solution in the reagent containing region and the oil agent in the pre-sealed oil storage structure without injecting the oil agent from the outside. In addition, the generated droplets may be respectively stored in the upper droplet containing region 470 and the lower droplet containing region 450.
Referring to
The bottom portion of the tubular structure 500 may be a smooth and flat surface so that a detection module below the tubular structure 500 may directly detect the droplets in the second microchannel 545 through the bottom portion of the tubular structure 500.
In the embodiment of the disclosure, an inner diameter of the first microchannel 515 may be, for example, 0.05 to 0.5 mm, and an inner diameter of the second microchannel 545 may be, for example, 0.1 to 1 mm. In addition, the inner diameter of the first microchannel 515 may be less than the inner diameter of the second microchannel 545, so that the formed droplet may be completely wrapped by the oil film.
A method of using the tubular structure 500 to produce droplets is similar to the method of using the tubular structure 300 to produce droplets, and a difference there between is that the first microchannel 515 and the second microchannel 545 are arranged near a bottom plane, which facilitates direct detection after the formation of the droplets, and facilitates real-time adjustment of parameters such as a fluid-driven flow rate, etc. The droplets flow into the droplet containing region 550 after being produced, and an optical detection system may be disposed under the second microchannel 545, and whether any droplet has passed the second microchannel 545 may be determined through real-time detection of the optical detection system, so as to adjust the pressure driving system in real-time. After the droplets are produced, the tubular structure 500 may be subjected to a temperature control cycle to make a specimen in the droplets to carry out a polymerase chain reaction (PCR) to amplify the specimen in the droplets. For example, the temperature control cycle of the tubular structure 500 may be carried out by using a carrier with a heating function, but the disclosure is not limited thereto. After the PCR is ended, the pressure driving system may push the droplets to make the droplets to move from the droplet containing region 550 to the oil storage region 540 through the second microchannel 545. Therefore, the optical detection system may be again used to perform optical signal detection on the droplets passing through the second microchannel 545.
Namely, the steps such as droplet generation of the ddPCR, polymerase chain reaction, droplet detection, etc., may all be performed in the tubular structure 500 of the fifth embodiment of the disclosure without replacing consumables, so that a procedure of the ddPCR may be simplified to reduce the cost.
Referring to
The bottom portion of the tubular structure 600 may be a smooth and flat surface so that a detection module below the tubular structure 600 may directly detect the droplets in the second microchannel 645 through the bottom portion of the tubular structure 600.
In the embodiment of the disclosure, an inner diameter of the first microchannel 615 may be, for example, 0.05 to 0.5 mm, and an inner diameter of the second microchannel 645 may be, for example, 0.1 to 1 mm. In addition, the inner diameter of the first microchannel 615 may be less than the inner diameter of the second microchannel 645, so that the formed droplet may be completely wrapped by the oil film.
A method of using the tubular structure 600 to produce droplets is similar to the method of using the tubular structure 400 to produce droplets, and a difference there between is that the first microchannel 615 and the second microchannel 645 are arranged near a bottom plane, which facilitates direct detection after the droplets are formed, and facilitates real-time adjustment of parameters such as a fluid-driven flow rate, etc. The droplets flow into the lower droplet containing region 650 after being produced. An optical detection system may be disposed under the second microchannel 645, and whether any droplet has passed the second microchannel 645 may be determined through real-time detection of the optical detection system, so as to adjust the pressure driving system in real-time. After the droplets are produced, the tubular structure 600 may be subjected to a temperature control cycle to make a specimen in the droplets to carry out a PCR to amplify the specimen in the droplets. For example, the temperature control cycle of the tubular structure 600 may be carried out by using a carrier with a heating function, but the disclosure is not limited thereto. After the PCR is ended, the pressure driving system may push the droplets to make the droplets to move from the lower droplet containing region 650 to the lower pre-sealed oil storage region 640 through the second microchannel 645. Therefore, the optical detection system may be again used to perform optical signal detection on the droplets passing through the second microchannel 645.
Namely, the steps such as droplet generation of the ddPCR, polymerase chain reaction, droplet detection, etc., may all be performed in the tubular structure 600 of the sixth embodiment of the disclosure without replacing consumables, so that the procedure of the ddPCR may be simplified to reduce the cost.
Referring to
The tubular structures according to the embodiments of the disclosure may be formed by a polymer material. For example, the polymer material may be acrylonitrile-butadiene-styrene (ABS) copolymer, acrylonitrile-styrene resin (AS), bulk molding compound (BMC), cellulose acetate (CA), cellulose nitrate (CN), cyclo-olefin copolymer (COC), cyclo-olefin polymer (COP), ethyl cellulose (EC), epoxy resin (EP), ethylene vinyl acetate copolymer (EVA), perfluoro(ethylene-propylene) (FEP) plastic, fiber reinforced plastics (FRP), melamine formaldehyde resin (MF), polymethylmethacrylate (PMMA), polyamide (PA), polyarylate (PAR), polybutene (PB), poly(butylene terephthalate) (PBT), polycarbonate (PC), polydimethylsiloxane (PDMS), low density polyethylene (LDPE), high density polyethylene (HDPE), polymer ethylene (PE), poly(ether-ether-ketone) (PEEK), polyethylene terephthalate (PET), poly(ether sulfone) (PES), phenol-formaldehyde resin (PF), polyoxymethylene (POM), polypropylene (PP), polyphenylene oxide (PPO), poly(p-phenylene sulfide) (PPS), high impact polystyrene (HIPS), polystyrene (PS), poly sulfone (PSF), poly(tetrafluoroethylene) (PTFE), polyurethane (PU), polyvinyl alcohol (PVA), poly(vinyl acetate) (PVAC), poly(vinyl butyral) (PVB), polyvinyl chloride (PVC), polyvinyl chloride acetate (PVCA), polyvinylidene chloride (PVDC), polyvinyl formal (PVFM), saturated polyester (SP), urea formaldehyde resin (UF), unsaturated polyester (UP) or any combination thereof, but the disclosure is not limited thereto. The formed tubular structure may be transparent.
The tubular structures of the embodiments of the disclosure may be obtained by a general molding method such as blow molding, extrusion molding, pressure molding, injection molding, etc. The tubular structures of the embodiments of the disclosure may be manufactured by respectively manufacturing individual components and bonding the components together. For example, an upper portion component, a lower portion component, and the outer cover of the tubular structure may be respectively manufactured and then the components are bonded. There is no particular limitation on a bonding method of each of the components. For example, the bonding method may be hot-melt bonding, ultrasonic bonding, UV hardening, chemical bond bonding, adhesive bonding, tenon bonding, etc., but the disclosure is not limited thereto.
In the embodiments of the disclosure, a liquid driving module may be arranged above each of the tubular structures to serve as a power source to push the reagent solution and the oil agent in the tubular structure to pass through the microchannels through air, so as to make the oil agent wrapping the reagent solution in the second microchannel or the droplet containing region to form reagent-in-oil droplets. For example, the liquid driving module may include, for example, a power source such as a syringe pump, a peristaltic pump, etc. to push the air to drive the reagent solution and the oil agent in the tubular structure to form the droplets. In another embodiment, the tubular structure may be heated, and the air inside the tubular structure may drive the reagent solution and the oil agent. For example, the method for producing droplets of the disclosure may include using a heat source to drive the air while heating the reagent containing region and the oil filling channel, wherein the internal air simultaneously drives the reagent solution and the oil agent, and the oil agent wraps the reagent solution in the second microchannel to form the reagent-in-oil droplets.
In the embodiments of the disclosure, a detection module may be arranged below each of the tubular structures to detect the droplets in the tubular structure in real-time. To be specific, the detection module may directly detect the droplets in the second microchannel through the flat transparent bottom of the tubular structure. For example, electromagnetic field detection or optical detection may be used to detect the droplets. The electromagnetic field detection includes detecting an electromagnetic field signal intensity of the droplets by using a magnetic field, an electric field, and electromagnetic waves. The optical detection includes detecting a signal intensity of the droplets by using cold light, absorption light, fluorescent light, etc. To be specific, the detection module may be, for example, an optical microscope or a spectrum analyzer, but the disclosure is not limited thereto. The detection module may detect a droplet generation state in real-time when the droplets are produced, so as to adjust the parameters of the liquid drive module. Regarding the specimen that requires PCR amplification, the liquid driving module may be used to drive the droplets to pass through the second microchannel from the droplet containing region to implement the real-time detection after the PCR. Alternatively, quantitative concentration interpretation is performed on diluted specimen that does not require the PCR amplification.
For example, when it is required to detect trace pesticide molecules in a food specimen or an environmental specimen, Raman spectroscopy may be used to detect Raman scattering of the droplet to quantify the trace pesticide molecules in the droplet to determine a pesticide residue. When it is required to detect a trace metal in a food specimen or an environmental specimen, a coloring agent may be added to the specimen to react with the metal in the specimen to form a colored substance. Then, the tubular structure of the disclosure is used to produce droplets. A photometer is used to measure an absorption light intensity of the droplet to quantify a concentration of the trace metal in the droplet to determine content of heavy metal.
In the embodiment of the disclosure, the carrier carrying the tubular structure may have a temperature control function. The carrier may be used to heat the reagent storage region and the oil filling channel in the tubular structure during a droplet producing period to drive the reagent solution and the oil agent, or after the droplets are produced in the tubular structure, the carrier may be used to directly perform temperature control on the tubular structure to make the droplets in the tubular structure to carry on the PCR for amplification.
The disclosure is described in detail in the following examples. However, the following examples are only provided to describe the disclosure, and the disclosure is not limited to the following examples.
The middle type microchannel pre-sealed oil slot tubular structure of the fourth embodiment of the disclosure is manufactured through injection molding. A material thereof is polypropylene, and a finished product is divided into three parts: an upper part, a middle part, and a lower part, an outer diameter of the tubular structure is 6 mm, and the three parts are bonded through ultrasonic welding in the middle for integration. Referring to
The lower type microchannel pre-sealed oil slot tubular structure of the sixth embodiment of the disclosure is manufactured through injection molding in the example 2. A material thereof is polypropylene, and a finished product includes several parts made separately, and upper and lower portions of each part are connected to form an integral tubular structure.
Experimental examples of using the tubular structures of the disclosure to perform ddPCR are described below.
The reagent solution used in the example of the disclosure is prepared according to reagent components, concentrations, and volumes shown in a following table 1.
According to parameters and reagents of a following table 2, the same method as that in the example 1 is used to produce tubular structures with different microchannel sizes, and different flow rates are used to simultaneously push the reagent solutions and the oil agent (droplet generation oil for probes; purchased from Bio-Rad). The generated droplets are collected and are observed by using an optical microscope.
In
The carrier module may be used to place the tubular structure of the disclosure and perform temperature control on the droplet region in the tubular structure to perform the PCR. In the following, the carrier modules suitable for the tubular structures of the disclosure are described in more detail by way of examples. However, the carrier modules suitable for the tubular structures of the disclosure are not limited thereto.
Referring to
Referring to
Referring to
Referring to
In the experiment example C, the heating carrier modules of the experimental example B-1, the experimental example B-2, the experimental example B-3, and the experimental example B-4 are respectively applied to perform temperature cycle tests to compare temperature control effects of the different heating carrier modules.
A general commercial PCR tube (purchased from Axygen; model No. PCR-02-C) and a tubular structure of the example 1 are respectively placed inside the carrier. 200 μL of oil (CAS No. 8042-47-5; purchased from Tedia) is filled in the PCR tube. 30 μL of oil is respectively filled in the middle and an outer side of the tubular structure of the example 1. Platinum temperature sensors are inserted into each slot in the PCR tube and the tubular structure of the example 1, and a temperature of each sensing position is recorded by a memory-type four-window thermometer (TM-947SD) to compare temperature variation curves of each of the sensing points varied along with time under a same temperature control condition.
The design of the T-shaped heating carrier has an effect of double-sided heating, but the large volume of metal reduces the response rate of heating and cooling. Taking a temperature variation in a side slot of the tubular structure as an example, it takes 59 seconds for heating from 30° C. to 80° C., and a heating rate is about 0.85° C./sec; and it takes 28 seconds for cooling from 90° C. to 60° C., and a cooling rate is about 1.1° C./sec.
The single-plane thin shell plate heating carrier module of the experimental example B-2 is used to perform the temperature cycle test. Three tubular structures of the example 1 are placed inside the carrier, and 30 μL of oil (CAS No. 8042-47-5; purchased from Tedia) is respectively filled in an inner side and the outer side of the tubular structures of the example 1, and platinum temperature sensors are inserted into each slot inside the tubes, and a temperature of each sensing position is recorded by a memory-type four-window thermometer (TM-947SD) to compare temperature variation curves of each of the sensing points varied along with time under a same cycle temperature control condition.
In the single-plane thin shell plate heating carrier of the experimental example B-2, since a metal volume of the carrier is reduced, the response rate of heating and cooling is greatly improved when the same temperature control equipment is used. Taking a temperature variation in the inner side slot of the tubular structure as an example, it takes 24 seconds for heating from 30° C. to 80° C., and the heating rate is about 2.1° C./sec; and it takes 21 seconds for cooling from 90° C. to 60° C., and the cooling rate is about 1.4° C./sec. The single-plane thin shell plate heating carrier of the experimental example B-2 may implement more effective temperature control on the tubular structures of the disclosure.
The single-plane sleeve-type heating carrier module of the experimental example B-3 is used to perform the temperature cycle test. A single tubular structure of the example 1 is placed in the middle inside the carrier, and 30 μL of oil (CAS No. 8042-47-5; purchased from Tedia) is respectively filled in the inner side, the middle, and the outer side of the tubular structure of the example 1, and platinum temperature sensors are inserted into each slot inside the tube, and a temperature of each sensing position is recorded by a memory-type four-window thermometer (TM-947SD).
Cycle temperature control points are respectively set to 93° C., 57° C., and 71.5° C., a temperature sensor for feedback control is placed in a middle hole of the heating carrier, and the temperature sensors respectively measure temperatures of the oil in the inner side, middle, and outer side slots of the tubular structure to compare temperature variation curves of each of the sensing points varied along with time in a same cycle.
The multi-tube single-side flat-edge type heating carrier module of the experimental example B-4 is applied to perform the temperature cycle test. The carrier is wrapped by a heat insulation material, and three PCR tubes (purchased from Axygen; model No. PCR-02-C) are placed inside the carrier, and 20 μL of mineral oil (CAS No. 8042-47-5; purchased from Tedia) and 10 μL of the reagent solution B are filled in the PCR tubes. A platinum temperature sensor is inserted into an inner slot of each of the PCR tubes, and a temperature of each sensing position is recorded by a memory-type four-window thermometer (TM-947SD).
In the experimental example C-5, the cycle temperature control effects of the commercial PCR tube and the tubular structures of the disclosure are compared. Three commercial PCR tubes (purchased from Axygen; model No. PCR-02-C) and three tubular structures of the example 1 are respectively placed inside two multi-tube single-side flat-edge type heating carriers of the experimental example B-4. The commercial PCR tubes and the tubular structures according to the disclosure are respectively filled with 20 μL of the mineral oil (CAS No. 8042-47-5; purchased from Tedia) and 10 μL of the reagent solution B. A platinum temperature sensor is inserted into an inner slot of a middle tube, and a temperature of each sensing position is recorded by a memory-type four-window thermometer (TM-947SD), and temperature variation curves of each of the sensing points varied along with time are compared under the same temperature control condition.
In the experimental example C-6, effects of different materials of the cooling plate on the PCR cycle temperature are compared. A function of the cooling plate is to export and distribute the heat generated by the cooling chip to the cooling plate, and then expel it into the air by a fan. Namely, one side of the cooling chip is the heating carrier, and another side is the cooling plate. In case that other experimental conditions are fixed, brass and aluminum alloy are respectively used to produce the cooling plate. The multi-tube single-side flat-edge type heating carrier of the experimental example B-4 is used to perform the temperature cycle test. A commercial PCR tube is placed inside the heating carrier, and 20 μL of the mineral oil (CAS No. 8042-47-5; purchased from Tedia) and 10 μL of the reagent solution B are filled in the commercial PCR tube. A platinum temperature sensors is inserted into an inner slot of each of the tubes, and a temperature of each sensing position is recorded by a memory-type four-window thermometer (TM-947SD), and temperature variation curves of each of the sensing points varied along with time are compared under the same temperature control condition.
In the experimental example D-1, the tubular structure of the example 1 and the single-plane sleeve-type heating carrier module of the experimental example B-3 of the disclosure are used to perform the PCR test, and a test result thereof is compared with a result obtained by using the commercial PCR instrument to perform the PCR test. The experimental example adopts a loop mediated isothermal amplification (LAMP) method to perform the test. The commercial PCR instrument is a multi-fluorescent gene quantitative spectrometer (Applied Biosystems Inc., 7500, Real time PCR). After the PCR is ended, agarose gel electrophoresis is applied to detect a result of the PCR, so as to compare the results of performing the PCR test by using the experimental equipment of the disclosure and using the commercial PCR instrument in parallel comparison.
First, 20 μL of the reagent solution C and 20 μL of oil (CAS No. 8042-47-5; purchased from Tedia) are respectively added to the reagent containing region and the oil slot of the tubular structure of the example 1. The single-plane sleeve-type heating carrier module of the experimental example B-3 is used to respectively perform constant temperature PCR tests of constant temperatures of 66.5° C. and 65° C. for holding 90 minutes on the tubular structure. Moreover, the multi-fluorescent gene quantitative spectrometer is used to perform PCR amplification at an operating temperature of 65° C. by using the same reagent. Then, the agarose gel electrophoresis is applied to interpret a DNA amplification signal.
In the experimental example D-2, three commercial PCR tubes (purchased from Axygen; model No. PCR-02-C) are placed in the multi-tube single-side flat-edge type heating carrier of the experimental example B-4 equipped with a temperature control device to perform a PCR experiment. After the PCR experiment is completed, the agarose gel electrophoresis is applied to perform parallel comparison after the DNA amplification.
First, 10 μL of the PCR reagent solution B and 20 μL of oil (CAS No. 8042-47-5; purchased from Tedia) are filled in the commercial PCR tubes, and a cycle temperature test is performed after sealing. In the multi-tube single-side flat-edge type heating carrier module of the experimental example B-4, the temperature is first raised to 95° C. and held for 10 minutes, and then a double-temperature layer multiple thermal cycle experiment is performed to carry out a DNA amplification experiment test. Fixed parameters of the experiment are a high temperature of 95° C. and a low temperature of 62.5° C., and operating control parameters are respectively a high temperature holding time, a low temperature holding time and a number of times of the thermal cycles. A control parameter test of the DNA amplification is performed, and a result thereof is shown in
The experimental results show that by using the multi-tube single-side flat-edge type heating carrier of the experimental example B-4 equipped with the temperature control device and using the commercial PCR tube to perform the DNA amplification test, the result of DNA signal amplification may be achieved under controlled operating conditions.
In the experimental Example D-3, three tubular structures of the example 1 are placed in the multi-tube single-side flat-edge type heating carrier of the experimental example B-4 equipped with the temperature control device for PCR experiment. Meanwhile, a 96-well PCR thermal cycler (Applied Biosystems Inc., Veriti) is used to perform a reagent verification test, and agarose gel electrophoresis is applied to perform parallel comparison after DNA amplification.
First, 20 μL of the PCR reagent solution B and 20 μL of oil (CAS No. 8042-47-5; purchased from Tedia) are filled in the inner side slot of the tubular structure of the example 1, and the cycle temperature test is performed after sealing. In the multi-tube single-side flat-edge type heating carrier module of the experimental example B-4, the temperature cycle test is performed for 35 times between two set temperatures of a high temperature of 95° C. and a low temperature of 62.5° C. Moreover, a commercial 96-well PCR thermal cycler (Applied Biosystems Inc., Veriti) is used to perform the verification test, and a same reagent is applied to perform parallel comparison. The results are shown in
In this experiment, agarose gel electrophoresis is applied to interpret the DNA amplification signal,
In the experiment example D-4, the PCR test results of different systems and different tubes under different operating conditions are compared. In the experimental example D-4, a commercial PCR tube (purchased from Axygen; model No. PCR-02-C) and a tubular structure of the example 1 are respectively placed in the multi-tube single-side flat-edge type heating carrier of the experimental example B-4 equipped with the temperature control device for performing the PCR experiment. Meanwhile, a 96-well PCR thermal cycler (Applied Biosystems Inc., Veriti) is used to perform a reagent verification test.
First, 20 μL of the mineral oil (CAS No. 8042-47-5; purchased from Tedia) and 10 μL of the reagent solution B are filled in each tube. Then, the PCR experiment is performed according to the experimental operating parameters of the table 5. After the PCR experiment is completed, agarose gel electrophoresis is applied to perform parallel comparison after the DNA amplification. The operating conditions of the experimental example D-4 and the result of agarose gel electrophoresis are shown in
This series of experiments prove that by using the heating carriers of the disclosure in collaboration with the commercial PCR tube and the tubular structures of the disclosure, the result of DNA amplification may all be achieved.
In summary, the disclosure provides a tubular structure for ddPCR and a method of using the tubular structure to produce droplets. The tubular structure may be used for droplet generation, polymerase chain reaction and/or detection, which reduces consumption of consumables of the ddPCR, simplifies a flow of the ddPCR, and reduces the cost of the ddPCR.
It will be apparent to those skilled in the art that various modifications and variations can be made to the structure of the disclosed embodiments without departing from the scope or spirit of the disclosure. In view of the foregoing, it is intended that the disclosure cover modifications and variations of this disclosure provided they fall within the scope of the following claims and their equivalents.
This application claims the priority benefit of U.S. provisional application Ser. No. 62/784,841, Dec. 26, 2018. The entirety of the above-mentioned patent application is hereby incorporated by reference herein and made a part of this specification.
Number | Name | Date | Kind |
---|---|---|---|
5759780 | Parker et al. | Jun 1998 | A |
5759781 | Ward et al. | Jun 1998 | A |
6387626 | Shi et al. | May 2002 | B1 |
6590094 | Karlou-Eyrisch et al. | Jul 2003 | B2 |
6977145 | Fouillet et al. | Dec 2005 | B2 |
7033761 | Shafer | Apr 2006 | B2 |
7056513 | Cech et al. | Jun 2006 | B2 |
7233393 | Tomaney et al. | Jun 2007 | B2 |
7294503 | Quake et al. | Nov 2007 | B2 |
7303870 | Hunter et al. | Dec 2007 | B2 |
7405823 | Tomaney et al. | Jul 2008 | B2 |
7417726 | Kao et al. | Aug 2008 | B2 |
7429479 | Harding | Sep 2008 | B2 |
7460223 | Harding | Dec 2008 | B2 |
7586600 | Kao et al. | Sep 2009 | B2 |
7715004 | Tomaney et al. | May 2010 | B2 |
7803529 | Cantor et al. | Sep 2010 | B1 |
7816121 | Pollack et al. | Oct 2010 | B2 |
7846666 | Kurn | Dec 2010 | B2 |
7851158 | McKernan | Dec 2010 | B2 |
7883265 | Kotler et al. | Feb 2011 | B2 |
7998436 | Pollack et al. | Aug 2011 | B2 |
8053192 | Bignell et al. | Nov 2011 | B2 |
8053215 | Hwang et al. | Nov 2011 | B2 |
8067176 | Ohashi | Nov 2011 | B2 |
8089623 | Kao et al. | Jan 2012 | B2 |
8133671 | Williams et al. | Mar 2012 | B2 |
8182989 | Bignell et al. | May 2012 | B2 |
8189186 | Beer | May 2012 | B2 |
8293470 | Quake et al. | Oct 2012 | B2 |
8293471 | Gregg et al. | Oct 2012 | B2 |
8293475 | Okamoto | Oct 2012 | B2 |
8338166 | Beer et al. | Dec 2012 | B2 |
8367976 | Beer et al. | Feb 2013 | B2 |
8535889 | Larson et al. | Sep 2013 | B2 |
8574835 | Hinz et al. | Nov 2013 | B2 |
8658430 | Miller et al. | Feb 2014 | B2 |
8741571 | Rigatti et al. | Jun 2014 | B2 |
8748094 | Weitz et al. | Jun 2014 | B2 |
8765380 | Berka et al. | Jul 2014 | B2 |
8765381 | Rigatti et al. | Jul 2014 | B2 |
8822150 | Bignell et al. | Sep 2014 | B2 |
8822151 | Sambursky et al. | Sep 2014 | B2 |
8841071 | Link | Sep 2014 | B2 |
8841093 | Takahashi et al. | Sep 2014 | B2 |
8846581 | Gordon et al. | Sep 2014 | B2 |
8852952 | Pollack et al. | Oct 2014 | B2 |
8951721 | Pollack et al. | Feb 2015 | B2 |
8951732 | Pollack et al. | Feb 2015 | B2 |
9017993 | Schultz et al. | Apr 2015 | B2 |
9040288 | Handique et al. | May 2015 | B2 |
9052298 | Reed et al. | Jun 2015 | B2 |
9079148 | Rigatti et al. | Jul 2015 | B2 |
9080207 | Handique et al. | Jul 2015 | B2 |
9091649 | Pollack et al. | Jul 2015 | B2 |
9121047 | Schultz et al. | Sep 2015 | B2 |
9150852 | Samuels et al. | Oct 2015 | B2 |
9150915 | Esfandyarpour et al. | Oct 2015 | B2 |
9156010 | Colston, Jr. | Oct 2015 | B2 |
9170060 | Beer et al. | Oct 2015 | B2 |
9186643 | Griffiths et al. | Nov 2015 | B2 |
9187783 | Esfandyarpour et al. | Nov 2015 | B2 |
9213042 | Oldham et al. | Dec 2015 | B2 |
9216392 | Hindson et al. | Dec 2015 | B2 |
9222115 | Marble et al. | Dec 2015 | B2 |
9228229 | Olson et al. | Jan 2016 | B2 |
9243288 | Ness et al. | Jan 2016 | B2 |
9249461 | Hinz et al. | Feb 2016 | B2 |
9259734 | Williams et al. | Feb 2016 | B2 |
9266104 | Link | Feb 2016 | B2 |
9273355 | Shoemaker et al. | Mar 2016 | B2 |
9313833 | Beer | Apr 2016 | B2 |
9327303 | Wang et al. | May 2016 | B2 |
9328376 | Hiddessen et al. | May 2016 | B2 |
9376713 | Bashir et al. | Jun 2016 | B2 |
9388465 | Hindson et al. | Jul 2016 | B2 |
9410171 | Ortac et al. | Aug 2016 | B2 |
9427737 | Heredia et al. | Aug 2016 | B2 |
9433943 | Bashir et al. | Sep 2016 | B2 |
9441266 | Larson et al. | Sep 2016 | B2 |
9447459 | Van Eijk et al. | Sep 2016 | B2 |
9476856 | Pamula et al. | Oct 2016 | B2 |
9492797 | Makarewicz et al. | Nov 2016 | B2 |
9494520 | Link | Nov 2016 | B2 |
9499812 | Krishnan et al. | Nov 2016 | B2 |
9499863 | Drmanac et al. | Nov 2016 | B2 |
9500664 | Ness et al. | Nov 2016 | B2 |
9512478 | Bignell et al. | Dec 2016 | B2 |
9533305 | Esfandyarpour et al. | Jan 2017 | B2 |
9534216 | Link et al. | Jan 2017 | B2 |
9562837 | Link | Feb 2017 | B2 |
9580736 | Tan et al. | Feb 2017 | B2 |
9581736 | Jannard et al. | Feb 2017 | B2 |
9617589 | Ramsey et al. | Apr 2017 | B2 |
9624519 | Godwin et al. | Apr 2017 | B2 |
9625454 | Strey et al. | Apr 2017 | B2 |
9631230 | Davies et al. | Apr 2017 | B2 |
9637799 | Fan et al. | May 2017 | B2 |
9649635 | Hiddessen et al. | May 2017 | B2 |
9677069 | Rigatti et al. | Jun 2017 | B2 |
9689024 | Hindson et al. | Jun 2017 | B2 |
9695468 | Hindson et al. | Jul 2017 | B2 |
9701998 | Hindson et al. | Jul 2017 | B2 |
9719134 | Yoon et al. | Aug 2017 | B2 |
9725758 | Zengerle et al. | Aug 2017 | B2 |
9725765 | Pushkarev et al. | Aug 2017 | B2 |
9738930 | Nicol et al. | Aug 2017 | B2 |
9738931 | Hahn et al. | Aug 2017 | B2 |
9744513 | Viovy et al. | Aug 2017 | B2 |
9745617 | Larson et al. | Aug 2017 | B2 |
9745627 | van Eijk et al. | Aug 2017 | B2 |
9776146 | Schultz et al. | Oct 2017 | B2 |
9790546 | Froehlich et al. | Oct 2017 | B2 |
9803226 | Diehl et al. | Oct 2017 | B2 |
9816121 | Agresti et al. | Nov 2017 | B2 |
9822393 | Lowe et al. | Nov 2017 | B2 |
9827545 | Gauckler et al. | Nov 2017 | B2 |
9855559 | Marble et al. | Jan 2018 | B2 |
9856525 | McCoy et al. | Jan 2018 | B2 |
9861986 | Pollack et al. | Jan 2018 | B2 |
9896722 | Link | Feb 2018 | B2 |
9914957 | Hiddessen et al. | Mar 2018 | B2 |
9919277 | Griffiths et al. | Mar 2018 | B2 |
20130252262 | Srinivasan et al. | Sep 2013 | A1 |
20140179544 | Steenblock et al. | Jun 2014 | A1 |
20140363821 | Bashir et al. | Dec 2014 | A1 |
20150167066 | Link et al. | Jun 2015 | A1 |
20150211048 | Ramsey et al. | Jul 2015 | A1 |
20150253284 | Sudarsan et al. | Sep 2015 | A1 |
20150299768 | Ng et al. | Oct 2015 | A1 |
20150315631 | Handique et al. | Nov 2015 | A1 |
20150329891 | Tan et al. | Nov 2015 | A1 |
20150376605 | Jarosz et al. | Dec 2015 | A1 |
20150376609 | Hindson et al. | Dec 2015 | A1 |
20160194629 | Hinz et al. | Jul 2016 | A1 |
20160289670 | Samuels et al. | Oct 2016 | A1 |
20160333337 | Duffy et al. | Nov 2016 | A1 |
20160370352 | Murrell et al. | Dec 2016 | A1 |
20160378916 | Drmanac et al. | Dec 2016 | A1 |
20170009274 | Abate et al. | Jan 2017 | A1 |
20170058342 | Welsh | Mar 2017 | A1 |
20170145499 | Bignell et al. | May 2017 | A1 |
20170166959 | Hashimoto et al. | Jun 2017 | A1 |
20170211140 | Schmitt et al. | Jul 2017 | A1 |
20170233797 | Ramsey et al. | Aug 2017 | A1 |
20170321252 | Hindson et al. | Nov 2017 | A1 |
20170335385 | Hindson et al. | Nov 2017 | A1 |
20170356027 | Hindson et al. | Dec 2017 | A1 |
20170356036 | Davies et al. | Dec 2017 | A1 |
20170369921 | Tan et al. | Dec 2017 | A1 |
20180016634 | Hindson et al. | Jan 2018 | A1 |
20180030515 | Regev et al. | Feb 2018 | A1 |
20180073069 | Uehara | Mar 2018 | A1 |
20180334670 | Bharadwaj et al. | Nov 2018 | A1 |
Number | Date | Country |
---|---|---|
107513495 | Dec 2017 | CN |
2856177 | Apr 2015 | EP |
201212451 | Mar 2012 | TW |
I388829 | Mar 2013 | TW |
201329230 | Jul 2013 | TW |
2015086132 | Jun 2015 | WO |
2017130707 | Aug 2017 | WO |
Entry |
---|
Parng, Shaw-Hwa et al., A 3D tubular structure with droplet generation and temperature control for DNA amplifcation, Microfuidics and Nanofuidics (2021) 25:56. (Year: 2021). |
Bert Vogelstein, et al.,“Digital PCR”, Proc. Natl. Acad. Sci. USA vol. 96, Aug. 1999, pp. 9236-9241. |
Richard Williams, et al., “Amplification of complex gene libraries by emulsion PCR”, Nature Methods vol. 3 No. 7, Jul. 2006, pp. 545-550. |
“Office Action of Taiwan Counterpart Application”, dated Oct. 13, 2020, pp. 1-3. |
Number | Date | Country | |
---|---|---|---|
20200261903 A1 | Aug 2020 | US |
Number | Date | Country | |
---|---|---|---|
62784841 | Dec 2018 | US |